Hyperlipidaemia Clinical Trials

17 recruiting

Hyperlipidaemia Trials at a Glance

8 actively recruiting trials for hyperlipidaemia are listed on ClinicalTrialsFinder across 2 cities in 3 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Edmonton and Hong Kong. Lead sponsors running hyperlipidaemia studies include Dr Gregory Szto, MonashHeart, Monash Health, and Department of General Practice, The University of Adelaide.

Browse hyperlipidaemia trials by phase

Top cities for hyperlipidaemia trials

About Hyperlipidaemia Clinical Trials

Looking for clinical trials for Hyperlipidaemia? There are currently 17 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hyperlipidaemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hyperlipidaemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Implementation and Evaluation of a Pharmacist-led Diabetes Care Pathway in Alberta Community Pharmacies

Diabetes MellitusHypertensionHyperlipidaemia
University of Alberta600 enrolled1 locationNCT07339852
Recruiting
Not Applicable

Developing an AI Pharmacy Chatbot for the Population of Hong Kong

Artificial Intelligence (AI)HypertensionHyperglycaemia+1 more
The University of Hong Kong280 enrolled2 locationsNCT07037563
Recruiting

Supporting Healthy Futures: Testing care-enhancement strategies to increase annual Health Checks and improve care for Aboriginal and Torres Strait Islander clients in mainstream general practices

HypertensionDiabetesHyperlipidaemia
University of Newcastle3,300 enrolled1 locationACTRN12624001015538
Recruiting

TWO BIRDS - Intensive lifestyle and medication to help improve diabetes and fatty liver disease through weight loss

ObesityHypertensionType 2 Diabetes+1 more
Western Sydney Local Health District200 enrolled1 locationACTRN12619000931178
Recruiting

Does the use of personal activity trackers in patients after a heart attack result in an increase in exercise capacity.

ObesityAcute Coronary SyndromeHyperlipidaemia
MonashHeart, Monash Health200 enrolled1 locationACTRN12617000312347
Recruiting
Phase 2Phase 3

Effect of Sublingual (under the tongue) Rosuvastatin/Crestor (cholesterol/statin medication) in reducing the side effects experienced in subjects with high cholesterol & a history of cardiovascular disease (heart attack, coronary artery disease) with a known statin intolerance.

DiabetesHyperlipidaemia
Dr Gregory Szto20 enrolled1 locationACTRN12616001544460
Recruiting
Phase 1

Effect of Fucoidan on glucose control and markers of cardiometabolic health after chronic dosing

Insulin Resistance/sensitivityHypercholesterolaemiaObesity+3 more
University of Tasmania.80 enrolled1 locationACTRN12614000495628
Recruiting

Point of CARE testing in a general practice setting trial

DiabetesHyperlipidaemia and anticoagulantm therapy
Department of General Practice, The University of Adelaide6,836 enrolled1 locationACTRN12605000272695